Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A1 | P13866 | 2/20 | 0.52 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 10/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.46 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.45 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.45 |
| ▸ | CBS | P35520 | 1/20 | 0.45 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29011740 | 0.81 | SLC5A1 (0.59) | SLC5A1SLC5A2GAAMAPTKMT2A | |
| SCHEMBL28994753 | 0.77 | TDP1 (0.62) | SLC5A1SLC5A2GAAMAPTKMT2A | |
| SCHEMBL563313 | 0.76 | GAA (0.45) | SLC5A1SLC5A2GAAMAPTKMT2A | |
| SCHEMBL28062064 | 0.76 | TDP1 (0.56) | MAPTKMT2ATDP1AKR1C3 | |
| SCHEMBL455030 | 0.76 | KMT2A (0.59) | SLC5A1SLC5A2GAAMAPTKMT2A | |
| SCHEMBL20323322 | 0.75 | ESR1 (0.56) | GAAMAPTKMT2ATDP1 | |
| SCHEMBL28283295 | 0.73 | AKR1C3 (0.64) | MAPTKMT2ATDP1AKR1C3ALOX5 | |
| SCHEMBL31321650 | 0.72 | AKR1C3 (0.66) | KMT2AAKR1C3ALOX5 | |
| SCHEMBL1938569 | 0.72 | SLC5A1 (0.73) | SLC5A1SLC5A2GAAMAPTKMT2A | |
| SCHEMBL13978646 | 0.72 | KMT2A (0.66) | MAPTKMT2ATDP1AKR1C3APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10800725-B2 | Arylpropionyl-triketone antibacterial agents | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-10-13 | — | — | US | disclosed |
| US-20130289128-A1 | ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-10-31 | — | — | US | disclosed |
| WO-2012033846-A1 | ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2012-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130289128-A1 | ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS | POLR2H, POLR2A, POLR2E | SLC5A1 2423/4885SLC5A2 3409/4885GAA 1233/4885 |
| US-10800725-B2 | Arylpropionyl-triketone antibacterial agents | POLR2H, POLR2A, POLR2E | SLC5A1 2423/4885SLC5A2 3409/4885GAA 1233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.